The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats
Sato K., Nakagawa Y., Omodaka K., Asada H., Fujii S., Masaki K., Nakazawa T.
View publication
-
Technology
Drug Delivery
-
Categories
Preclinical development
-
Affiliations
Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan; Collaborative Program for Ophthalmic Drug Discovery, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Ophthalmic Imaging and Information Analytics, Tohoku University Graduate School of Medicine, Sendai, Japan; Pharmaceutical Technology Development, Global R&D, Santen Pharmaceutical Co., Ltd, Nara, Japan; Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Retinal Disease Control, Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan